Allergan (AGN) Enters ~$1.5B Licensing Agreement with AstraZeneca (AZN) for MEDI2070 Rights
Tweet Send to a Friend
Allergan plc (NYSE: AGN) announced that it has entered into a licensing agreement with MedImmune, AstraZeneca's global biologics research and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE